These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16384923)

  • 1. Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy.
    Ting-De Ravin SS; Kennedy DR; Naumann N; Kennedy JS; Choi U; Hartnett BJ; Linton GF; Whiting-Theobald NL; Moore PF; Vernau W; Malech HL; Felsburg PJ
    Blood; 2006 Apr; 107(8):3091-7. PubMed ID: 16384923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral transduction of IL2RG into CD34(+) cells from X-linked severe combined immunodeficiency patients permits human T- and B-cell development in sheep chimeras.
    Tsai EJ; Malech HL; Kirby MR; Hsu AP; Seidel NE; Porada CD; Zanjani ED; Bodine DM; Puck JM
    Blood; 2002 Jul; 100(1):72-9. PubMed ID: 12070011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
    Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
    Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ex vivo culture of CD34+ bone marrow cells on immune reconstitution of XSCID dogs following allogeneic bone marrow transplantation.
    Kennedy DR; McLellan K; Moore PF; Henthorn PS; Felsburg PJ
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):662-70. PubMed ID: 19450750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency.
    Felsburg PJ; Somberg RL; Hartnett BJ; Suter SF; Henthorn PS; Moore PF; Weinberg KI; Ochs HD
    Blood; 1997 Oct; 90(8):3214-21. PubMed ID: 9376605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral marking of canine bone marrow: long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes.
    Whitwam T; Haskins ME; Henthorn PS; Kraszewski JN; Kleiman SE; Seidel NE; Bodine DM; Puck JM
    Blood; 1998 Sep; 92(5):1565-75. PubMed ID: 9716584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency.
    Chinen J; Davis J; De Ravin SS; Hay BN; Hsu AP; Linton GF; Naumann N; Nomicos EY; Silvin C; Ulrick J; Whiting-Theobald NL; Malech HL; Puck JM
    Blood; 2007 Jul; 110(1):67-73. PubMed ID: 17369490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
    Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
    N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency.
    Candotti F; Johnston JA; Puck JM; Sugamura K; O'Shea JJ; Blaese RM
    Blood; 1996 Apr; 87(8):3097-102. PubMed ID: 8605322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issues.
    Medin JA; Fowler DH
    J Cell Biochem Suppl; 2002; 38():46-54. PubMed ID: 12046849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach.
    Lo M; Bloom ML; Imada K; Berg M; Bollenbacher JM; Bloom ET; Kelsall BL; Leonard WJ
    Blood; 1999 Nov; 94(9):3027-36. PubMed ID: 10556186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
    Smogorzewska EM; Weinberg KI; Kohn DB
    Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.
    Gaspar HB; Parsley KL; Howe S; King D; Gilmour KC; Sinclair J; Brouns G; Schmidt M; Von Kalle C; Barington T; Jakobsen MA; Christensen HO; Al Ghonaium A; White HN; Smith JL; Levinsky RJ; Ali RR; Kinnon C; Thrasher AJ
    Lancet; 2004 Dec 18-31; 364(9452):2181-7. PubMed ID: 15610804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome.
    Qazilbash MH; Walsh CE; Russell SM; Noguchi M; Mann MM; Leonard WJ; Liu JM
    J Hematother; 1995 Apr; 4(2):91-8. PubMed ID: 7633846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.
    Hartnett BJ; Yao D; Suter SE; Ellinwood NM; Henthorn PS; Moore PE; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2002; 8(4):188-97. PubMed ID: 12014808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
    Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
    Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo γ-retroviral gene therapy of dogs with X-linked severe combined immunodeficiency and the development of a thymic T cell lymphoma.
    Kennedy DR; Hartnett BJ; Kennedy JS; Vernau W; Moore PF; O'Malley T; Burkly LC; Henthorn PS; Felsburg PJ
    Vet Immunol Immunopathol; 2011 Jul; 142(1-2):36-48. PubMed ID: 21536334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial.
    Schmidt M; Hacein-Bey-Abina S; Wissler M; Carlier F; Lim A; Prinz C; Glimm H; Andre-Schmutz I; Hue C; Garrigue A; Le Deist F; Lagresle C; Fischer A; Cavazzana-Calvo M; von Kalle C
    Blood; 2005 Apr; 105(7):2699-706. PubMed ID: 15585650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo competitive studies between normal and common gamma chain-defective bone marrow cells: implications for gene therapy.
    Otsu M; Sugamura K; Candotti F
    Hum Gene Ther; 2000 Sep; 11(14):2051-6. PubMed ID: 11020803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer.
    Bunting KD; Sangster MY; Ihle JN; Sorrentino BP
    Nat Med; 1998 Jan; 4(1):58-64. PubMed ID: 9427607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.